Position in PCRX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$21,158
-$922 QoQ
Shares Held
834
-14.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#192
of 251 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 20261620 INVESTMENT ADVISORS, INC. holds $895,573 across 9 Drug Manufacturers - Specialty & Generic names. PCRX ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
24,191 | $384,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
356 | $192,891 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
997 | $168,034 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,577 | $53,428 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
407 | $45,152 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
This page
|
834 | $21,158 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
550 | $17,270 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
615 | $12,410 |
All Filings in PCRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,158 | 834 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $22,080 | 977 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $25,284 | 977 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $25,177 | 977 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $23,350 | 977 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $24,651 | 992 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $18,689 | 992 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $15,456 | 1,027 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $16,822 | 588 | Shares | Sole | 2024-07-23 | |
| No filing history on record for this holder in this stock. | ||||||